NGNE - Neurogene Inc.
NEXT EARNINGS:
Mar 23, 2026
(in 26 days)
EPS Est: $-1.20
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$45.00
DETAILS
HIGH:
$45.00
LOW:
$45.00
MEDIAN:
$45.00
CONSENSUS:
$45.00
UPSIDE:
138.10%
Market Cap:
292.76M
Volume:
55,086
Avg Volume:
156,210
52 Week Range:
6.875-37.266
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.04
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
107
IPO Date:
2014-03-07
EPS (TTM):
-4.28
P/E Ratio:
-5.34
Revenue (TTM):
925,000
Total Assets:
335.73M
Total Debt:
12.43M
Cash & Equiv:
136.59M
Rev Growth (5Y):
-42.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-23.4%
Debt/Equity:
0.04
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-13 | $-0.99 | $-1.26 | +21.4% | — | — | — |
| 2025-08-11 | $-1.05 | $-1.15 | +8.7% | — | — | — |
| 2025-05-09 | $-1.08 | $-1.05 | -2.9% | — | — | — |
| 2025-03-24 | $-0.99 | $-1.04 | +4.8% | — | — | — |
| 2024-11-18 | $-1.19 | $-1.22 | +2.5% | — | — | — |
| 2024-08-09 | $-1.09 | $-1.02 | -6.9% | $925000 | — | — |
| 2024-05-10 | $-1.00 | $-1.03 | +2.9% | — | — | — |
| 2024-03-26 | $-1.51 | $-1.17 | -29.1% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 925,000 | 0 | 0 | 0 | 0 | 0 | 25.00M | 0 | 0 | 0 | 0 | 0 |
| Net Income | (75.14M) | (36.32M) | (55.19M) | (50.52M) | (33.28M) | (69.44M) | (31.59M) | (50.18M) | (37.00M) | (21.86M) | (23.82M) | (8.73M) |
| EPS | -4.28 | -2.83 | -4.30 | -0.92 | -0.64 | -2.57 | -1.34 | -2.14 | -1.96 | -1.73 | -2.75 | -0.87 |
| Total Assets | 335.73M | 222.57M | 109.27M | 101.49M | 210.52M | 147.02M | 77.62M | 110.33M | 154.38M | 113.34M | 41.42M | 58.77M |
| Total Debt | 12.43M | 16.25M | 4.69M | 6.43M | 12.12M | 1.21M | 5,999 | 32,999 | 47,000 | 131,000 | 72,341 | 2.29M |
| Cash & Equivalents | 136.59M | 148.21M | 82.02M | 70.54M | 192.56M | 143.09M | 76.93M | 52.03M | 32.30M | 39.53M | 14.91M | 54.13M |
| Operating Cash Flow | (70.60M) | (51.42M) | (52.82M) | (46.40M) | (24.57M) | (15.39M) | (31.58M) | (44.72M) | (30.23M) | (20.27M) | (17.81M) | (7.94M) |
| Free Cash Flow | (71.41M) | (51.74M) | (55.05M) | (64.77M) | (26.79M) | (16.27M) | (31.63M) | (45.21M) | (30.94M) | (20.30M) | (17.92M) | (7.95M) |
| FCF per Share | -4.07 | -4.03 | -4.29 | -1.18 | -0.52 | -0.60 | -1.34 | -1.93 | -1.64 | -1.61 | -2.07 | -0.79 |
| Book Value | 310.38M | 186.02M | 98.63M | (91.88M) | 191.22M | 141.69M | 72.67M | 98.89M | 144.66M | 108.42M | 36.15M | 51.28M |
| Cash & ST Investments | 312.40M | 197.16M | 82.02M | 70.54M | 192.56M | 143.09M | 76.93M | 108.08M | 103.06M | 74.48M | 39.10M | 56.95M |
| ROC Equity | -0.24 | -0.20 | -0.56 | N/A | -0.17 | -0.49 | -0.43 | -0.51 | -0.26 | -0.20 | -0.66 | -0.17 |